Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
32.48
+0.40 (1.25%)
Mar 18, 2026, 12:51 PM EDT - Market open
Nanobiotix Employees
Nanobiotix had 103 employees as of June 30, 2025. The number of employees decreased by 5 or -4.63% since the number was reported on December 31, 2024.
Employees
103
Change
-5
Growth
-4.63%
Revenue / Employee
$115,832
Profits / Employee
-$588,830
Market Cap
1.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 103 | -5 | -4.63% | 103 | 0 |
| Dec 31, 2024 | 108 | 6 | 5.88% | 108 | 0 |
| Dec 31, 2023 | 102 | 0 | - | 102 | 0 |
| Dec 31, 2022 | 102 | 2 | 2.00% | 102 | 0 |
| Dec 31, 2021 | 100 | 10 | 11.11% | 100 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 298 |
| Harmony Biosciences Holdings | 293 |
| Innoviva | 159 |
| Pharvaris | 118 |
NBTX News
- 5 days ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 20 days ago - NANOBIOTIX to Participate in Investor Conferences in March - GlobeNewsWire
- 4 weeks ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 5 weeks ago - Nanobiotix (NBTX) Sees Significant Price Target Increase by Guggenheim | NBTX Stock News - GuruFocus
- 2 months ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 3 months ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 3 months ago - NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris - GlobeNewsWire
- 4 months ago - Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook - GlobeNewsWire